1). Lee JY, Ko KS. Antimicrobial resistance and clones of Acinetobacter species and Pseudomonas aeruginosa. J Bacteriol Virol. 2012; 42:1–8.
2). Mussi MA, Limansky AS, Aiale AM. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins. Antimicrob Agents Chemother. 2005; 49:1432–40.
3). Lee Y, Kim CK, Lee H, Jeong SH, Yong D, Lee K. A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the bla(OXA-23) gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011; 55:361–3.
4). Moffat JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010; 54:4971–7.
5). Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; approved guideline. CLSI Document M100-S23. Clinical and Laboratory Standards Institute;Wayne, PA: 2013.
6). Park YK, Jung SI, Park KH, Kim SH, Ko KS. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in Korea. Int J Antimicrob Agents. 2012; 39:81–5.